Clinical Trials

The SOLX Gold Shunt is not yet commercially available in the US. It is currently being studied in an FDA-cleared clinical trial in the US. This study is focused on establishing the safety and effectiveness of the device in reducing intraocular pressure in patients with refractory glaucoma. Check back to this website and www.clinicaltrials.gov for the most up-to-date information about our ongoing studies.